---
type: "WebPage"
title: "Fusaricidin analysis laboratory"
description: "As a biopharmaceutical manufacturer, you wish to carry out a fusaricidin analysis What is fusaricidin? Fusaricidin is a peptide antibiotic composed of six amino acids. It is recognized for its promising antifungal potential. This molecule is at the heart of..."
resource: "https://filab.fr/en/sectors-of-activity/biopharmaceutical/fusaricidin-analysis/"
tags: ["EN", "pll_67ae0ce2abd19", "Anaïs DECAUX"]
timestamp: "2025-12-31T08:32:32Z"
published: "2025-02-14T09:24:19Z"
language: "en"
author: "Laure Durieux"
---

# Fusaricidin analysis laboratory

## As a biopharmaceutical manufacturer, you wish to carry out a fusaricidin analysis

### What is fusaricidin?

Fusaricidin is a [peptide](https://filab.fr/en/sectors-of-activity/biopharmaceutical/biotherapeutic-recombinant-protein-characterization/peptide-analysis-laboratory-by-lc-ms.md) antibiotic composed of six [amino acids](https://filab.fr/en/our-services/our-analysis-services/chemical-analysis-laboratory/analysis-amino-acids.md). It is recognized for its promising antifungal potential. This molecule is at the heart of advanced research thanks to its involvement in the fight against major pathogens.

### Why carry out a fusaridicin analysis?

Fusaricidin analysis plays a key role in :

**The development of new antibiotics** based on natural metabolites.

**Assessing the purity and efficacy of formulations** to ensure compliance with pharmaceutical standards.

**Characterization of biomedicines** containing compounds of microbial origin.

**Monitoring bacterial strains**to guarantee their stability and reproducibility in an industrial context.

## FILAB assists biopharmaceutical manufacturers with fusaricidin analysis

### Why choose FILAB?

The FILAB laboratory, a laboratory of analytical expertise, offers analysis services for your fusaridicins using cutting-edge techniques adapted to industrial constraints and regulatory requirements. Our analytical approach enables us to identify, quantify and characterise the fusaricidins in your samples to guarantee the conformity of your products.

## Our analysis services

Identification and characterization of glycosylated structures

Additional structural characterization

Characterization of therapeutic [glycoproteins](https://filab.fr/en/sectors-of-activity/biopharmaceutical/biotherapeutic-recombinant-protein-characterization/analysis-characterization-glycoproteins.md), [biosimilars](https://filab.fr/en/sectors-of-activity/biopharmaceutical/biotherapeutic-recombinant-protein-characterization/analysis-characterization-biosimilars.md) and [vaccines](https://filab.fr/en/our-services/our-expertise-services/laboratory-analysis-injectable-drugs/laboratory-for-the-analysis-of-injectable-products-and-pharmaceutical-vaccines.md).

[Analysis of peptide aggregates](https://filab.fr/en/sectors-of-activity/biopharmaceutical/peptide-aggregation-analysis-laboratory.md)

Separation and analysis of derivatised glycans

[Glycosylation analysis](https://filab.fr/en/sectors-of-activity/biopharmaceutical/glycosylation-analysis.md)

Study of glycans in [peptides](https://filab.fr/en/sectors-of-activity/biopharmaceutical/biotherapeutic-recombinant-protein-characterization/peptide-analysis-biopharmaceutical-services.md) and bioactive [proteins](https://filab.fr/en/sectors-of-activity/biopharmaceutical/biotherapeutic-recombinant-protein-characterization/protein-analysis.md)

[ N-glycans analysis](https://filab.fr/en/sectors-of-activity/biopharmaceutical/n-glycans-analysis.md)

[UPLC](https://filab.fr/en/our-technical-resources/laboratory-analysis-uplc.md)

[FTIR](https://filab.fr/en/our-technical-resources/laboratory-analysis-ftir-spectroscopy.md)

[LC-MS](https://filab.fr/en/our-technical-resources/altis-lc-msms-analysis.md)

[NMR](https://filab.fr/en/our-technical-resources/laboratory-analysis-nmr.md)

  ![](https://filab.fr/wp-content/uploads/2024/10/shutterstock_1712752057-anticorps-monoclonaux.jpg)